Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: Results from a phase Ib/IIa study

  1. Martin, M.
  2. Fumoleau, P.
  3. Dewar, J.A.
  4. Albanell, J.
  5. Limentani, S.A.
  6. Campone, M.
  7. Chang, J.C.
  8. Patre, M.
  9. Strasak, A.
  10. de Haas, S.L.
  11. Xu, J.
  12. Garcia-Saenz, J.A.
Revista:
Annals of Oncology

ISSN: 1569-8041 0923-7534

Any de publicació: 2016

Volum: 27

Número: 7

Pàgines: 1249-1256

Tipus: Article

DOI: 10.1093/ANNONC/MDW157 GOOGLE SCHOLAR lock_openAccés obert editor